Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-01

FDA Approved: JUBLIA — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approves a supplemental application for JUBLIA (efinaconazole) from Bausch Health US LLC, potentially updating labeling or adding new information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUBLIA (efinaconazole)

Snippet

SUPPL AP for JUBLIA (EFINACONAZOLE)